Blueprint Investment Partners LLC Pfizer Inc Transaction History

Blueprint Investment Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $792,540 - $1.03 Million	18,983 New	18,983 $973,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $593,024 - $703,141	12,745 Added 97.11%	25,869 $1.36 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $38,475 - $47,676	-841 Reduced 6.02%	13,124 $679,000
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $216,475 - $320,888	5,239 Added 60.04%	13,965 $824,000
Q3 2021 Nov 04, 2021	BUY	$39.25 - $50.42 $342,495 - $439,964	8,726 New	8,726 $375,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.